Invention Grant
- Patent Title: Combination of a MC1R receptor agonist and UVB for the treatment and/or prevention of pigmentation disorders
-
Application No.: US14385416Application Date: 2013-03-15
-
Publication No.: US09610461B2Publication Date: 2017-04-04
- Inventor: Carole Chomat , Philippe Martel , Johannes Voegel
- Applicant: GALDERMA RESEARCH & DEVELOPMENT
- Applicant Address: FR Biot
- Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee: GALDERMA RESEARCH & DEVELOPMENT
- Current Assignee Address: FR Biot
- Agency: Dentons US LLP
- International Application: PCT/EP2013/055434 WO 20130315
- International Announcement: WO2013/135880 WO 20130919
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61N5/06 ; A61K38/33 ; A61K38/34 ; A61K38/35 ; A61K45/06 ; A61K31/397 ; A61K31/40 ; A61K31/445 ; A61K31/4178 ; A61K31/4196 ; A61K31/435 ; A61K31/454
Abstract:
A system comprising a combination of at least one MCI R receptor agonist and a source of NB-UVB, wherein said system is adapted for simultaneous or sequential use of said MC1R receptor agonist and said NB-UVB in amounts effective for the treatment and/or prevention of dermatological conditions linked to a hypopigmentation.
Public/Granted literature
Information query
IPC分类:
